|
|
.
See Category: Diseases of the skin and subcutaneous tissue
ICD-10 (CM) Code and Descriptor
|
L90.5 |
Scar conditions and fibrosis of skin
|
L905 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 18.41%
|
25.57%
|
18.32%
|
12.03%
|
7.99%
|
5.39%
|
3.61%
|
2.58%
|
1.95%
|
1.42%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for L90.5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
7,844
|
7,854
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
6,402
|
7,462
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
3,380
|
7,500
|
|
97110
|
THERAPEUTIC EXERCISES |
2,237
|
3,822
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,325
|
38,236
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,274
|
2,077
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,077
|
4,696
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
922
|
3,610
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
822
|
1,755
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
791
|
6,645
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
789
|
5,332
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
657
|
1,089
|
|
17000
|
DESTRUCT PREMALG LESION |
639
|
644
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
629
|
629
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
566
|
637
|
|
J7120
|
RINGERS LACTATE INFUSION |
562
|
706
|
|
97530
|
THERAPEUTIC ACTIVITIES |
523
|
724
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
485
|
1,286
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
437
|
437
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
430
|
484
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
L90.5 related to the following DRG Codes:
606-607
|
